Seeking Alpha

RegeneRx receives last $1M from license and security purchase agreement

  • RegeneRx Biopharmaceuticals (OTCQB:RGRX +17.1%) receives the final payment of $1M of the $2.5M product license and securities purchase agreement with G-treeBNT Co., Ltd. Proceeds have been dedicated to the development of the RegeneRx's RGN-259, a preservative-free eye drop product for certain Asian markets.
  • G-treeBNT purchased 8,333,333 shares of RGRX common stock at $0.12 per share and retains an option to purchase an additional shares for $825K at $0.15 per share until January 31, 2015.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: